Icosapent ethyl modulates circulating vascular regenerative cell content: The IPE-PREVENTION CardioLink-14 trial.
Bakbak E, Krishnaraj A, Bhatt DL, Quan A, Park B, Bakbak AI, Bari B, Terenzi KA, Pan Y, Fry EJ, Terenzi DC, Puar P, Khan TS, Rotstein OD, Mazer CD, Leiter LA, Teoh H, Hess DA, Verma S.
Bakbak E, et al. Among authors: puar p.
Med. 2024 Mar 27:S2666-6340(24)00121-1. doi: 10.1016/j.medj.2024.03.009. Online ahead of print.
Med. 2024.
PMID: 38552629